Jack Willis
ID: UNCST-2022-R008869
|
Increasing Demand for Agricultural Insurance: The Role of the Timing of Premium Payments
REFNo: A316ES
Increase insurance uptake among smallholder farmers,
|
UK |
2023-07-27 21:03:47 |
2026-07-27 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Kelsey Morgan Babikov Rae
ID:
|
Adapting and Piloting a Survivor-Led Case Management Tool ("Freedom Greenlight")
REFNo: SS1827ES
2. The research aims to pilot the Freedom Greenlight tool in Uganda. There are two phases to the research project. Phase 1 - Tool Adaptation (Nearly Completed) During Phase 1, we aimed to validate the usage of the Freedom Greenlight tool in Uganda. Key Willow personnel and survivors participated in a workshop with these guiding questions: 1. Which word choices, images, and indicators from the global Freedom Greenlight are culturally recognizable and contextually relevant? Which need to be adapted for relevance to the Uganda context, and in what way? 2. Which locally relevant indicators should be added to the tool when it is used by Willow’s Uganda-based aftercare program? All adaptations are reviewed by research personnel, experts in the Greenlight methodology, and a clinical psychologist. The adaptations will be incorporated into the tool before Phase 2 begins. Phase 2 - Pilot Freedom Greenlight (Duration: Enroll participants for six months beginning in November/December 2022; collect endline data through November 2023) We will pilot the tool, using random assignment of participants in order to evaluate the effectiveness of using the Freedom Greenlight case management tool compared to current standards of care. We are interested in learning how the Freedom Greenlight process impacts well-being, economic outcomes, and reintegration outcomes. Interviews will be conducted to further understand case managers’ and participants’ experiences with the Freedom Greenlight,1. Adapting and Piloting a Survivor-Led Case Management Tool (“Freedom Greenlight”),
|
USA |
2023-07-27 21:01:23 |
2026-07-27 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Sofie Bjerregaard Budhoo
ID: UNCST-2022-R010093
|
Waiting in the Social Aftermath of Access: An ethnographic examination of the development of local social dynamics and perceptions of justice in Odek in the wake of the International Criminal Court’s Access to Justice project
REFNo: SS1875ES
• How will local perceptions of justice and the International Criminal Court develop over time in Odek after the Court’s Access to Justice Project has ended?,• How will local patterns of behaviour and social dynamics develop over time in Odek in relation to the ICC’s justice processes and following reparations phase after the AJP has ended? ,
|
Denmark |
2023-07-27 20:59:38 |
2026-07-27 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Mary Nanteza Bridget
ID:
|
The trend of rubella virus infection among antenatal mothers and burden of other teratogenic pathogens in children presenting with congenital defects in Uganda.
REFNo: HS2895ES
1.The aim of the study is to determine the trend of active rubella infections among teenage antenatal mothers and assess the impact of the vaccine roll out. It will also investigate the trend of active rubella infections in mothers who tested positive for HIV infection and those who tested negative.
2.We would like to explore leveraging the Rubella Surveillance cohort of children with congenital defects and determine the incidence of CMV IgM / cytomegavirus disease burden in children. Through this collaboration, the study also targets other etiological pathogens that are linked to congenital defects namely varicella zoster virus (VZV), herpes simplex virus (HSV), lympho-choriomeningitis virus (LCMV), parvovirus 19 (B19V), zika virus (ZIKV) and toxoplasmosis gondii (TOXO).
3.Another objective is to sequence and genotype rubella and CMV in samples from children who test positive for the retrospective pathogens in the CRS cohort.
|
Uganda |
2023-07-27 20:58:09 |
2026-07-27 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Janelle Wagnild
ID:
|
Evaluation of risk communication campaigns and development of a practical handbook for member states
REFNo: SS1825ES
To conduct a systematic evaluation of the reach and impact of national risk communication campaigns in four African countries (Ghana, Nigeria, Sierra Leone and Uganda) on SF medical products, paying careful attention to possible differences by socioeconomic group, urban/rural settings, region, age and gender.
Drawing on the evaluation findings, to develop an evidence-based practical handbook for WHO Member States (globally) on strengthening risk communication on SF medical products, sharing best practice and ensuring feasibility for use in resource-constrained contexts.
|
USA |
2023-07-27 20:56:49 |
2026-07-27 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|